Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals

Am J Obstet Gynecol MFM. 2020 May;2(2):100118. doi: 10.1016/j.ajogmf.2020.100118. Epub 2020 Apr 9.

Abstract

Novel coronavirus disease 2019 is rapidly spreading throughout the New York metropolitan area since its first reported case on March 1, 2020. The state is now the epicenter of coronavirus disease 2019 outbreak in the United States, with 84,735 cases reported as of April 2, 2020. We previously presented an early case series with 7 coronavirus disease 2019-positive pregnant patients, 2 of whom were diagnosed with coronavirus disease 2019 after an initial asymptomatic presentation. We now describe a series of 43 test-positive cases of coronavirus disease 2019 presenting to an affiliated pair of New York City hospitals for more than 2 weeks, from March 13, 2020, to March 27, 2020. A total of 14 patients (32.6%) presented without any coronavirus disease 2019-associated viral symptoms and were identified after they developed symptoms during admission or after the implementation of universal testing for all obstetric admissions on March 22. Among them, 10 patients (71.4%) developed symptoms of coronavirus disease 2019 over the course of their delivery admission or early after postpartum discharge. Of the other 29 patients (67.4%) who presented with symptomatic coronavirus disease 2019, 3 women ultimately required antenatal admission for viral symptoms, and another patient re-presented with worsening respiratory status requiring oxygen supplementation 6 days postpartum after a successful labor induction. There were no confirmed cases of coronavirus disease 2019 detected in neonates upon initial testing on the first day of life. Based on coronavirus disease 2019 disease severity characteristics by Wu and McGoogan, 37 women (86%) exhibited mild disease, 4 (9.3%) severe disease, and 2 (4.7%) critical disease; these percentages are similar to those described in nonpregnant adults with coronavirus disease 2019 (about 80% mild, 15% severe, and 5% critical disease).

Keywords: COVID-19; novel coronavirus; pregnancy.

MeSH terms

  • Adult
  • Ambulatory Care*
  • Anti-Bacterial Agents / therapeutic use
  • Asymptomatic Diseases
  • Azithromycin / therapeutic use
  • COVID-19 / complications
  • COVID-19 / diagnosis
  • COVID-19 / physiopathology
  • COVID-19 / therapy*
  • COVID-19 Nucleic Acid Testing
  • Carrier State / diagnosis
  • Cesarean Section*
  • Disease Management
  • Enzyme Inhibitors / therapeutic use
  • Female
  • Fluid Therapy
  • Gestational Age
  • Hospitalization*
  • Hospitals, Community
  • Hospitals, University
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Infection Control / methods
  • Intensive Care Units
  • Labor, Induced*
  • Labor, Obstetric
  • Multi-Institutional Systems
  • New York City
  • Obesity, Maternal / complications
  • Obstetric Labor, Premature
  • Oxygen Inhalation Therapy
  • Pregnancy
  • Pregnancy Complications, Infectious / diagnosis
  • Pregnancy Complications, Infectious / physiopathology
  • Pregnancy Complications, Infectious / therapy*
  • Retrospective Studies
  • SARS-CoV-2
  • Telemedicine
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Enzyme Inhibitors
  • Hydroxychloroquine
  • Azithromycin